Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Breast Cancer Stem Cells
Lu Zhang, Wen‐Ming Chen, Suling Liu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 2, pp. 552-570
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Molecular Pathways of Genistein Activity in Breast Cancer Cells
Evangelia Konstantinou, Aristea Gioxari, Maria Dimitriou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5556-5556
Open Access | Times Cited: 22
The role of cancer stem cells in relapse of solid tumors
Yang Yu
Frontiers in Bioscience-Elite (2011) Vol. E4, Iss. 1, pp. 1528-1528
Open Access | Times Cited: 133
Cuproptosis and cuproptosis-related genes: Emerging potential therapeutic targets in breast cancer
Xiangdong Liu, Bo Luo, Xinhong Wu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189013-189013
Closed Access | Times Cited: 28
Curcumin and nanodelivery systems: New directions for targeted therapy and diagnosis of breast cancer
Ruhong Zhou, Jie Gong, Xianguang Deng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117404-117404
Open Access | Times Cited: 13
KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges
Changyun Li, Wanhe Wang, Chung‐Hang Leung, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Unraveling the underlying mechanisms of cancer stem cells in therapeutic resistance for optimizing treatment strategies
Yunhan Tan, Siyuan Qin, Zhe Zhang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 1
The role of the mTOR pathway in breast cancer stem cells (BCSCs): mechanisms and therapeutic potentials
Chen Zhang, Shu Xu, Chuanzheng Yin, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
A promising target for breast cancer: B7-H3
Ying Jiang, Jiayu Liu, Lingyan Chen, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
PP2A as a potential therapeutic target for breast cancer: Current insights and future perspectives
Yalong Qi, Lixi Li, Yuhan Wei, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116398-116398
Open Access | Times Cited: 7
Peptide Inhibitor Targeting the Extraterminal Domain in BRD4 Potently Suppresses Breast Cancer Both In Vitro and In Vivo
Qi-xuan Huang, Da-meng Fan, Zaozao Zheng, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6658-6672
Open Access | Times Cited: 6
Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy
Bemrew Admassu Mengistu, Tirunesh Tsegaw, Yitayew Demessie, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment
Bruno Ricardo Barreto Pires, Ísis Salviano Soares de Amorim, Layane Duarte e Souza, et al.
Anticancer Research (2016) Vol. 36, Iss. 11, pp. 5681-5692
Open Access | Times Cited: 55
Phytochemicals: Current strategies for treating breast cancer (Review)
Bridg’ette Israel, Syreeta L. Tilghman, Kitani Parker‐Lemieux, et al.
Oncology Letters (2018)
Open Access | Times Cited: 52
Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer
Panpan Huang, Ruocen Liao, Xingyu Chen, et al.
Theranostics (2020) Vol. 10, Iss. 10, pp. 4644-4658
Open Access | Times Cited: 40
FAXC interacts with ANXA2 and SRC in mitochondria and promotes tumorigenesis in cholangiocarcinoma
Haruna Fujimori, Mao Shima‐Nakamura, Shin-ichiro Kanno, et al.
Cancer Science (2024) Vol. 115, Iss. 6, pp. 1896-1909
Open Access | Times Cited: 5
Cisplatin and TRAIL enhance breast cancer stem cell death
Shuping Yin, Liping Xu, Subhayu Bandyopadhyay, et al.
International Journal of Oncology (2011)
Open Access | Times Cited: 50
Polymer–lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells
Jun Li, Wenqing Xu, Xiaoli Yuan, et al.
International Journal of Nanomedicine (2017) Vol. Volume 12, pp. 6909-6921
Open Access | Times Cited: 43
Effects of miRNAs on functions of breast cancer stem cells and treatment of breast cancer
Ying Zhang, Bin Xu, Xiping Zhang
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 4263-4270
Open Access | Times Cited: 42
Molecular Pathways of Rosmarinic Acid Anticancer Activity in Triple-Negative Breast Cancer Cells: A Literature Review
Evangelia Konstantinou, Athanassios Panagiotopoulos, Konstantina Argyri, et al.
Nutrients (2023) Vol. 16, Iss. 1, pp. 2-2
Open Access | Times Cited: 11
Combination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways
Fang Tian, Shiheng Hu, Xinhao Song, et al.
Breast Cancer Research and Treatment (2024) Vol. 207, Iss. 2, pp. 435-451
Closed Access | Times Cited: 4
Crosstalk between miRNAs and signaling pathways in the development of drug resistance in breast cancer
Reza Amiri, Poorya Najjari Nabi, Ahmad Fazilat, et al.
Hormone Molecular Biology and Clinical Investigation (2024)
Closed Access | Times Cited: 4
Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application
Murshid Imam, Jiale Ji, Zhijie Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
The role of circular RNAs in glucose metabolic reprogramming: impact on cancer progression and therapeutic implications in breast cancer
Yiran Liang, Qifeng Yang
Journal of Cancer Metastasis and Treatment (2025)
Open Access
Biomarkers, isolation methods, and therapeutic implications of breast cancer stem cells
Peik Lin Teoh, Neha Saini
Cancer Pathogenesis and Therapy (2025)
Open Access
Circular RNAs in cancer stem cells: Insights into their roles and mechanisms (Review)
Lunyu Yang, Yuling Yi, Zhu Mei, et al.
International Journal of Molecular Medicine (2025) Vol. 55, Iss. 3
Closed Access
Page 1 - Next Page

Scroll to top